2018-2023 Global Injectable Anticoagulants Consumption Market Report

Publisher Name :
Date: 12-Jul-2018
No. of pages: 139

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Injectable Anticoagulants market for 2018-2023.

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).

In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.

The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.

Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.

Over the next five years, LPI(LP Information) projects that Injectable Anticoagulants will register a 2.7% CAGR in terms of revenue, reach US$ 6440 million by 2023, from US$ 5490 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Anticoagulants market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Low-molecular-weight Heparin (LMWH)

- Direct Thrombin Inhibitor (DTI)

- Other

Segmentation by application:

- VTE

- ACS/MI

- AF

- Other

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Sanofi

- Genentech (Roche)

- Boehringer Ingelheim

- Pfizer

- The Medicines Company

- Aspen

- Otsuka

- ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Injectable Anticoagulants consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Injectable Anticoagulants market by identifying its various subsegments.

- Focuses on the key global Injectable Anticoagulants manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Injectable Anticoagulants with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Injectable Anticoagulants submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Injectable Anticoagulants Consumption Market Report

Table of Contents

2018-2023 Global Injectable Anticoagulants Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injectable Anticoagulants Consumption 2013-2023
2.1.2 Injectable Anticoagulants Consumption CAGR by Region
2.2 Injectable Anticoagulants Segment by Type
2.2.1 Low-molecular-weight Heparin (LMWH)
2.2.2 Direct Thrombin Inhibitor (DTI)
2.2.3 Other
2.3 Injectable Anticoagulants Consumption by Type
2.3.1 Global Injectable Anticoagulants Consumption Market Share by Type (2013-2018)
2.3.2 Global Injectable Anticoagulants Revenue and Market Share by Type (2013-2018)
2.3.3 Global Injectable Anticoagulants Sale Price by Type (2013-2018)
2.4 Injectable Anticoagulants Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Other
2.5 Injectable Anticoagulants Consumption by Application
2.5.1 Global Injectable Anticoagulants Consumption Market Share by Application (2013-2018)
2.5.2 Global Injectable Anticoagulants Value and Market Share by Application (2013-2018)
2.5.3 Global Injectable Anticoagulants Sale Price by Application (2013-2018)

3 Global Injectable Anticoagulants by Players
3.1 Global Injectable Anticoagulants Sales Market Share by Players
3.1.1 Global Injectable Anticoagulants Sales by Players (2016-2018)
3.1.2 Global Injectable Anticoagulants Sales Market Share by Players (2016-2018)
3.2 Global Injectable Anticoagulants Revenue Market Share by Players
3.2.1 Global Injectable Anticoagulants Revenue by Players (2016-2018)
3.2.2 Global Injectable Anticoagulants Revenue Market Share by Players (2016-2018)
3.3 Global Injectable Anticoagulants Sale Price by Players
3.4 Global Injectable Anticoagulants Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Injectable Anticoagulants Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Injectable Anticoagulants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Injectable Anticoagulants by Regions
4.1 Injectable Anticoagulants by Regions
4.1.1 Global Injectable Anticoagulants Consumption by Regions
4.1.2 Global Injectable Anticoagulants Value by Regions
4.2 Americas Injectable Anticoagulants Consumption Growth
4.3 APAC Injectable Anticoagulants Consumption Growth
4.4 Europe Injectable Anticoagulants Consumption Growth
4.5 Middle East & Africa Injectable Anticoagulants Consumption Growth

5 Americas
5.1 Americas Injectable Anticoagulants Consumption by Countries
5.1.1 Americas Injectable Anticoagulants Consumption by Countries (2013-2018)
5.1.2 Americas Injectable Anticoagulants Value by Countries (2013-2018)
5.2 Americas Injectable Anticoagulants Consumption by Type
5.3 Americas Injectable Anticoagulants Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Injectable Anticoagulants Consumption by Countries
6.1.1 APAC Injectable Anticoagulants Consumption by Countries (2013-2018)
6.1.2 APAC Injectable Anticoagulants Value by Countries (2013-2018)
6.2 APAC Injectable Anticoagulants Consumption by Type
6.3 APAC Injectable Anticoagulants Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Injectable Anticoagulants by Countries
7.1.1 Europe Injectable Anticoagulants Consumption by Countries (2013-2018)
7.1.2 Europe Injectable Anticoagulants Value by Countries (2013-2018)
7.2 Europe Injectable Anticoagulants Consumption by Type
7.3 Europe Injectable Anticoagulants Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Injectable Anticoagulants by Countries
8.1.1 Middle East & Africa Injectable Anticoagulants Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Injectable Anticoagulants Value by Countries (2013-2018)
8.2 Middle East & Africa Injectable Anticoagulants Consumption by Type
8.3 Middle East & Africa Injectable Anticoagulants Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Injectable Anticoagulants Distributors
10.3 Injectable Anticoagulants Customer

11 Global Injectable Anticoagulants Market Forecast
11.1 Global Injectable Anticoagulants Consumption Forecast (2018-2023)
11.2 Global Injectable Anticoagulants Forecast by Regions
11.2.1 Global Injectable Anticoagulants Forecast by Regions (2018-2023)
11.2.2 Global Injectable Anticoagulants Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Injectable Anticoagulants Forecast by Type
11.8 Global Injectable Anticoagulants Forecast by Application

12 Key Players Analysis
12.1 Sanofi
12.1.1 Company Details
12.1.2 Injectable Anticoagulants Product Offered
12.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Sanofi News
12.2 Genentech (Roche)
12.2.1 Company Details
12.2.2 Injectable Anticoagulants Product Offered
12.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Genentech (Roche) News
12.3 Boehringer Ingelheim
12.3.1 Company Details
12.3.2 Injectable Anticoagulants Product Offered
12.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Boehringer Ingelheim News
12.4 Pfizer
12.4.1 Company Details
12.4.2 Injectable Anticoagulants Product Offered
12.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Pfizer News
12.5 The Medicines Company
12.5.1 Company Details
12.5.2 Injectable Anticoagulants Product Offered
12.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 The Medicines Company News
12.6 Aspen
12.6.1 Company Details
12.6.2 Injectable Anticoagulants Product Offered
12.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Aspen News
12.7 Otsuka
12.7.1 Company Details
12.7.2 Injectable Anticoagulants Product Offered
12.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Otsuka News
...

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Injectable Anticoagulants
Table Product Specifications of Injectable Anticoagulants
Figure Injectable Anticoagulants Report Years Considered
Figure Market Research Methodology
Figure Global Injectable Anticoagulants Consumption Growth Rate 2013-2023 (K Units)
Figure Global Injectable Anticoagulants Value Growth Rate 2013-2023 ($ Millions)
Table Injectable Anticoagulants Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Low-molecular-weight Heparin (LMWH)
Table Major Players of Low-molecular-weight Heparin (LMWH)
Figure Product Picture of Direct Thrombin Inhibitor (DTI)
Table Major Players of Direct Thrombin Inhibitor (DTI)
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Injectable Anticoagulants Consumption Market Share by Type (2013-2018)
Figure Global Injectable Anticoagulants Consumption Market Share by Type (2013-2018)
Table Global Injectable Anticoagulants Revenue by Type (2013-2018) ($ million)
Table Global Injectable Anticoagulants Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Injectable Anticoagulants Value Market Share by Type (2013-2018)
Table Global Injectable Anticoagulants Sale Price by Type (2013-2018)
Figure Injectable Anticoagulants Consumed in VTE
Figure Global Injectable Anticoagulants Market: VTE (2013-2018) (K Units)
Figure Global Injectable Anticoagulants Market: VTE (2013-2018) ($ Millions)
Figure Global VTE YoY Growth ($ Millions)
Figure Injectable Anticoagulants Consumed in ACS/MI
Figure Global Injectable Anticoagulants Market: ACS/MI (2013-2018) (K Units)
Figure Global Injectable Anticoagulants Market: ACS/MI (2013-2018) ($ Millions)
Figure Global ACS/MI YoY Growth ($ Millions)
Figure Injectable Anticoagulants Consumed in AF
Figure Global Injectable Anticoagulants Market: AF (2013-2018) (K Units)
Figure Global Injectable Anticoagulants Market: AF (2013-2018) ($ Millions)
Figure Global AF YoY Growth ($ Millions)
Figure Injectable Anticoagulants Consumed in Other
Figure Global Injectable Anticoagulants Market: Other (2013-2018) (K Units)
Figure Global Injectable Anticoagulants Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Injectable Anticoagulants Consumption Market Share by Application (2013-2018)
Figure Global Injectable Anticoagulants Consumption Market Share by Application (2013-2018)
Table Global Injectable Anticoagulants Value by Application (2013-2018)
Table Global Injectable Anticoagulants Value Market Share by Application (2013-2018)
Figure Global Injectable Anticoagulants Value Market Share by Application (2013-2018)
Table Global Injectable Anticoagulants Sale Price by Application (2013-2018)
Table Global Injectable Anticoagulants Sales by Players (2016-2018) (K Units)
Table Global Injectable Anticoagulants Sales Market Share by Players (2016-2018)
Figure Global Injectable Anticoagulants Sales Market Share by Players in 2016
Figure Global Injectable Anticoagulants Sales Market Share by Players in 2017
Table Global Injectable Anticoagulants Revenue by Players (2016-2018) ($ Millions)
Table Global Injectable Anticoagulants Revenue Market Share by Players (2016-2018)
Figure Global Injectable Anticoagulants Revenue Market Share by Players in 2016
Figure Global Injectable Anticoagulants Revenue Market Share by Players in 2017
Table Global Injectable Anticoagulants Sale Price by Players (2016-2018)
Figure Global Injectable Anticoagulants Sale Price by Players in 2017
Table Global Injectable Anticoagulants Manufacturing Base Distribution and Sales Area by Players
Table Players Injectable Anticoagulants Products Offered
Table Injectable Anticoagulants Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Injectable Anticoagulants Consumption by Regions 2013-2018 (K Units)
Table Global Injectable Anticoagulants Consumption Market Share by Regions 2013-2018
Figure Global Injectable Anticoagulants Consumption Market Share by Regions 2013-2018
Table Global Injectable Anticoagulants Value by Regions 2013-2018 ($ Millions)
Table Global Injectable Anticoagulants Value Market Share by Regions 2013-2018
Figure Global Injectable Anticoagulants Value Market Share by Regions 2013-2018
Figure Americas Injectable Anticoagulants Consumption 2013-2018 (K Units)
Figure Americas Injectable Anticoagulants Value 2013-2018 ($ Millions)
Figure APAC Injectable Anticoagulants Consumption 2013-2018 (K Units)
Figure APAC Injectable Anticoagulants Value 2013-2018 ($ Millions)
Figure Europe Injectable Anticoagulants Consumption 2013-2018 (K Units)
Figure Europe Injectable Anticoagulants Value 2013-2018 ($ Millions)
Figure Middle East & Africa Injectable Anticoagulants Consumption 2013-2018 (K Units)
Figure Middle East & Africa Injectable Anticoagulants Value 2013-2018 ($ Millions)
Table Americas Injectable Anticoagulants Consumption by Countries (2013-2018) (K Units)
Table Americas Injectable Anticoagulants Consumption Market Share by Countries (2013-2018)
Figure Americas Injectable Anticoagulants Consumption Market Share by Countries in 2017
Table Americas Injectable Anticoagulants Value by Countries (2013-2018) ($ Millions)
Table Americas Injectable Anticoagulants Value Market Share by Countries (2013-2018)
Figure Americas Injectable Anticoagulants Value Market Share by Countries in 2017
Table Americas Injectable Anticoagulants Consumption by Type (2013-2018) (K Units)
Table Americas Injectable Anticoagulants Consumption Market Share by Type (2013-2018)
Figure Americas Injectable Anticoagulants Consumption Market Share by Type in 2017
Table Americas Injectable Anticoagulants Consumption by Application (2013-2018) (K Units)
Table Americas Injectable Anticoagulants Consumption Market Share by Application (2013-2018)
Figure Americas Injectable Anticoagulants Consumption Market Share by Application in 2017
Figure United States Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure United States Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Canada Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Canada Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Mexico Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Mexico Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Table APAC Injectable Anticoagulants Consumption by Countries (2013-2018) (K Units)
Table APAC Injectable Anticoagulants Consumption Market Share by Countries (2013-2018)
Figure APAC Injectable Anticoagulants Consumption Market Share by Countries in 2017
Table APAC Injectable Anticoagulants Value by Countries (2013-2018) ($ Millions)
Table APAC Injectable Anticoagulants Value Market Share by Countries (2013-2018)
Figure APAC Injectable Anticoagulants Value Market Share by Countries in 2017
Table APAC Injectable Anticoagulants Consumption by Type (2013-2018) (K Units)
Table APAC Injectable Anticoagulants Consumption Market Share by Type (2013-2018)
Figure APAC Injectable Anticoagulants Consumption Market Share by Type in 2017
Table APAC Injectable Anticoagulants Consumption by Application (2013-2018) (K Units)
Table APAC Injectable Anticoagulants Consumption Market Share by Application (2013-2018)
Figure APAC Injectable Anticoagulants Consumption Market Share by Application in 2017
Figure China Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure China Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Japan Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Japan Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Korea Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Korea Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure India Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure India Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Australia Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Australia Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Table Europe Injectable Anticoagulants Consumption by Countries (2013-2018) (K Units)
Table Europe Injectable Anticoagulants Consumption Market Share by Countries (2013-2018)
Figure Europe Injectable Anticoagulants Consumption Market Share by Countries in 2017
Table Europe Injectable Anticoagulants Value by Countries (2013-2018) ($ Millions)
Table Europe Injectable Anticoagulants Value Market Share by Countries (2013-2018)
Figure Europe Injectable Anticoagulants Value Market Share by Countries in 2017
Table Europe Injectable Anticoagulants Consumption by Type (2013-2018) (K Units)
Table Europe Injectable Anticoagulants Consumption Market Share by Type (2013-2018)
Figure Europe Injectable Anticoagulants Consumption Market Share by Type in 2017
Table Europe Injectable Anticoagulants Consumption by Application (2013-2018) (K Units)
Table Europe Injectable Anticoagulants Consumption Market Share by Application (2013-2018)
Figure Europe Injectable Anticoagulants Consumption Market Share by Application in 2017
Figure Germany Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Germany Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure France Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure France Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure UK Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure UK Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Italy Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Italy Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Russia Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Russia Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Spain Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Spain Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Injectable Anticoagulants Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Injectable Anticoagulants Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Injectable Anticoagulants Consumption Market Share by Countries in 2017
Table Middle East & Africa Injectable Anticoagulants Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Injectable Anticoagulants Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Injectable Anticoagulants Value Market Share by Countries in 2017
Table Middle East & Africa Injectable Anticoagulants Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Injectable Anticoagulants Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Injectable Anticoagulants Consumption Market Share by Type in 2017
Table Middle East & Africa Injectable Anticoagulants Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Injectable Anticoagulants Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Injectable Anticoagulants Consumption Market Share by Application in 2017
Figure Egypt Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Egypt Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure South Africa Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure South Africa Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Israel Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Israel Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure Turkey Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure Turkey Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Injectable Anticoagulants Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Injectable Anticoagulants Value Growth 2013-2018 ($ Millions)
Table Injectable Anticoagulants Distributors List
Table Injectable Anticoagulants Customer List
Figure Global Injectable Anticoagulants Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Injectable Anticoagulants Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Injectable Anticoagulants Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Injectable Anticoagulants Consumption Market Forecast by Regions
Table Global Injectable Anticoagulants Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Injectable Anticoagulants Value Market Share Forecast by Regions
Figure Americas Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Americas Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure APAC Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure APAC Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Europe Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Europe Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Middle East & Africa Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Middle East & Africa Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure United States Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure United States Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Canada Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Canada Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Mexico Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Mexico Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Brazil Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Brazil Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure China Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure China Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Japan Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Japan Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Korea Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Korea Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Southeast Asia Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Southeast Asia Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure India Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure India Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Australia Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Australia Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Germany Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Germany Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure France Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure France Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure UK Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure UK Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Italy Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Italy Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Russia Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Russia Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Spain Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Spain Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Egypt Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Egypt Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure South Africa Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure South Africa Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Israel Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Israel Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure Turkey Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure Turkey Injectable Anticoagulants Value 2018-2023 ($ Millions)
Figure GCC Countries Injectable Anticoagulants Consumption 2018-2023 (K Units)
Figure GCC Countries Injectable Anticoagulants Value 2018-2023 ($ Millions)
Table Global Injectable Anticoagulants Consumption Forecast by Type (2018-2023) (K Units)
Table Global Injectable Anticoagulants Consumption Market Share Forecast by Type (2018-2023)
Table Global Injectable Anticoagulants Value Forecast by Type (2018-2023) ($ Millions)
Table Global Injectable Anticoagulants Value Market Share Forecast by Type (2018-2023)
Table Global Injectable Anticoagulants Consumption Forecast by Application (2018-2023) (K Units)
Table Global Injectable Anticoagulants Consumption Market Share Forecast by Application (2018-2023)
Table Global Injectable Anticoagulants Value Forecast by Application (2018-2023) ($ Millions)
Table Global Injectable Anticoagulants Value Market Share Forecast by Application (2018-2023)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Injectable Anticoagulants Market Share (2016-2018)
Table Genentech (Roche) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Genentech (Roche) Injectable Anticoagulants Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Injectable Anticoagulants Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Injectable Anticoagulants Market Share (2016-2018)
Table The Medicines Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table The Medicines Company Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
Figure The Medicines Company Injectable Anticoagulants Market Share (2016-2018)
Table Aspen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Aspen Injectable Anticoagulants Market Share (2016-2018)
Table Otsuka Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Otsuka Injectable Anticoagulants Market Share (2016-2018)
  • Global Hemophilia Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 118
    Hemophilia is a hereditary genetic disorder which impairs body's ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, coagulation does not occur. Of the two types of hemophilia, hemophilia A has higher prevalence compared to the other variant hemophilia B. . Acquired hemophilia is a rare non genetic form of hemophilia in which autoantibodies develop against the plasma coagulation factor. The development......
  • 2015-2023 World Hemophilia Treatment Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 18-Sep-2018        Price: US 2800 Onwards        Pages: 81
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc)......
  • 2015-2023 World Intravenous Immunoglobulins Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 17-Sep-2018        Price: US 2800 Onwards        Pages: 82
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc)......
  • Global Intravenous Immunoglobulin (IVIg) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Sep-2018        Price: US 3480 Onwards        Pages: 134
    Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin. Scope of the Report: This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report......
  • 2018-2023 India Heparin Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 83
    In 2017, the Heparin market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai - Yino......
  • Global Fibrinogen Concentrates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Sep-2018        Price: US 3480 Onwards        Pages: 117
    Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer's product are justly used in local region or countries.......
  • 2018-2023 Philippines Heparin Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 83
    In 2017, the Heparin market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai......
  • 2018-2023 UK Heparin Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 83
    In 2017, the Heparin market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai - Yino Pharm......
  • 2018-2023 United States Heparin Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 83
    In 2017, the Heparin market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinb......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs